Atlas Trials

Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Clinical trial NCT00113646 · TERMINATED

Trial details

NCT number
NCT00113646
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LymphomaLeukemiaMultiple MyelomaMyelodysplastic Syndrome
Start date
2002-11-01
Primary completion
2007-12-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.